McGill University researchers have identified a brain function that helps explain why childhood stress raises metabolic health risks for some women later in life. A new study found that variations in ...
McGill University researchers have identified a brain function that helps explain why childhood stress raises metabolic health risks for some women later in life. A new study found that variations in ...
The hormone adrenomedullin disrupts insulin signaling in blood vessel cells, contributing to systemic insulin resistance in obesity-associated type 2 diabetes, according to a new study. Blocking ...
Developing resistance to insulin is a key step on the road to diabetes, making insulin resistance a target for treating metabolic dysfunction. Insulin orchestrates blood glucose levels by signaling ...
Adrenomedullin disrupts insulin signaling in blood vessels, leading to systemic insulin resistance in obesity-associated type 2 diabetes, according to a new study by a team at the Max Planck Institute ...
Assistant Professor of Biology Emrah Altindis has been awarded a five-year, $2.5-million grant from the National Institutes of Health to advance his research on viral insulins into the understanding ...
Glucagon-like peptide-1 receptor agonists, known as GLP-1 drugs, are highly effective at helping people lose weight and ...
Recent advances in type 2 diabetes treatment are reshaping care for patients with chronic kidney disease (CKD). SGLT2 inhibitors and GLP-1 receptor agonists now have FDA approval for slowing kidney ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results